REA reaffirms commitment to EEP sustainability at 2024 SEF, focusing on solar hybrid power plant sustainability in 37 federal universities and 7 teaching hospitals. 24 universities and 4 hospitals have been included in three phases, with 15 institutions signing a collaborative agreement to ensure project sustainability.
Three trials show polypills improve hypertension control, reduce polypharmacy. QUADRO, GMRx2, and VERONICA trials demonstrate efficacy of combination pills in diverse populations.
George Medicines presents results from two Phase III trials of GMRx2, a novel, low-dose, triple combination pill for hypertension, showing significant BP reduction and improved control rates with good tolerability at ESC Congress 2024.